Lv31
230 积分 2025-08-01 加入
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
2个月前
已完结
Groundbreaking mRNA Lung Cancer Vaccine Trials: A New Dawn in Cancer Treatment
3个月前
已完结
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
3个月前
已完结
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
3个月前
已完结
Clinical advances of mRNA vaccines for cancer immunotherapy
3个月前
已完结
Recent advances in therapeutic cancer vaccines
3个月前
已完结
Cancer vaccines: the next immunotherapy frontier
3个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
3个月前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
3个月前
已完结
皖公网安备34019202002308
